AQP4 and neuromyelitis optica: NMO is an astrocytopathy with the distinctive presence of AQP4 autoantibodies and complement activation with loss of immunoreactivities for the astrocytic proteins, AQP4 and glial fibrillary acidic protein (GFAP) [57].